Related Experiment Videos
Pharmacy Education and Transition to Practice in Indonesia
Sherly Meilianti1,2, Lailaturrahmi3,4, Dimas Aditya Suhendar5
1School of Pharmacy, Applied Sciences and Public Health, Robert Gordon University.
Biological & Pharmaceutical Bulletin
|August 3, 2026
Summary
Ensuring Indonesian pharmacy graduates are practice-ready is challenging due to gaps in training and assessment. This review examines the pharmacy education pipeline, identifying key issues in competency development and national standards.
Area of Science:
- Health Professions Education
- Pharmacy Practice
- Workforce Development
Background:
- Pharmacy education in Indonesia aims to equip graduates for diverse health system roles, but workforce studies reveal persistent challenges in ensuring practice readiness.
- Capability gaps, uneven distribution, and service delivery variations highlight issues in preparing new pharmacists for current demands.
Purpose of the Study:
- To review the Indonesian pharmacy education pipeline, mapping competency specification, teaching, and assessment from education to early professional transition.
- To synthesize national policies and standards influencing pharmacy curriculum and assurance, including professional standards, learning outcomes, accreditation, and national examinations.
Main Methods:
- An evidence-informed narrative review synthesizing national policy documents, standards, and empirical studies on Indonesian pharmacy education.
- Analysis of the undergraduate and professional pharmacy programs, including supervised work-based learning and implementation considerations.
Main Results:
- Key challenges identified include institutional/placement capacity variations, difficulties in translating competencies to observable performance in experiential learning, and debates surrounding national assessments.
- Limitations noted include sparse national outcome data, limited reporting on experiential learning, and a lack of longitudinal evidence connecting education to practice outcomes.
Conclusions:
- Addressing heterogeneity in educational capacity and improving the translation of competencies into practical skills are crucial for enhancing pharmacy graduate readiness.
- Further research is needed on the impact of educational processes and national assessments on early-career pharmacist performance and health service outcomes.
Related Concept Videos
01:28IV Infusion to Oral Dosing: Conversion Methods
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...